Here are my favorite stocks:
GlaxoSmithKline (NYSE:GSK) has a market capitalization of $114.39 billion. The company employs 96,461 people, generates revenues of $44,734.36 million and has a net income of $2,919.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,615.36 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $2.05. Last fiscal year, the company paid $2.05 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 22.07, Price/Sales 2.50 and Price/Book ratio 8.10. Dividend Yield: 4.95 percent. The beta ratio is 0.61.
| Long-Term Stock History Chart Of GlaxoSmithKline plc (ADR) (Click to enlarge) |
| Long-Term Dividends History of GlaxoSmithKline plc (ADR) (GSK) (Click to enlarge) |
| Long-Term Dividend Yield History of GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge) |
Johnson & Johnson (NYSE:JNJ) has a market capitalization of $179.39 billion. The company employs 117,000 people, generates revenues of $65,030.00 million and has a net income of $9,672.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $12,841.00 million. Because of these figures, the EBITDA margin is 19.75 percent (operating margin 19.01 percent and the net profit margin finally 14.87 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $3.48. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 18.86, Price/Sales 2.77 and Price/Book ratio is not calculable. Dividend Yield: 3.46 percent. The beta ratio is 0.55.
| Long-Term Stock History Chart Of Johnson & Johnson (Click to enlarge) |
| Long-Term Dividends History of Johnson & Johnson (JNJ) (Click to enlarge) |
| Long-Term Dividend Yield History of Johnson & Johnson (NYSE: JNJ) (Click to enlarge) |
Abbott Laboratories (NYSE:ABT) has a market capitalization of $84.53 billion. The company employs 90,000 people, generates revenues of $38,851.00 million and has a net income of $4,729.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5,615.00 million. Because of these figures, the EBITDA margin is 14.45 percent (operating margin 14.45 percent and the net profit margin finally 12.17 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $3.00. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 18.06, Price/Sales 2.17 and Price/Book ratio is not calculable. Dividend Yield: 3.55 percent. The beta ratio is 0.29.
| Long-Term Stock History Chart Of Abbott Laboratories (Click to enlarge) |
| Long-Term Dividends History of Abbott Laboratories (ABT) (Click to enlarge) |
| Long-Term Dividend Yield History of Abbott Laboratories (NYSE: ABT) (Click to enlarge) |
![]() |
| The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth (Click to enlarge) |

Their has been so very much negative news surrounding any stocks involved in healthcare over the last ten years rarly do you hear anything positive about anything in healthcare arena. That being said healthcare will continue to expand faster than the over all economy. So I believe that many of the stocks being talked about above will become more attractive as time goes by.
ReplyDelete